Table 2 Serum levels of PFASs in different groups (N = 4561).
From: Association of PFDeA exposure with hypertension (NHANES, 2013–2018)
Number, median (Q1, Q3) | Total | Non-Hypertension | Hypertension | P |
|---|---|---|---|---|
4561 | 3026 | 1535 | ||
PFDeA, ng/mL | 0.2 (0.1–0.3) (mean: 0.3) | 0.2 (0.1–0.3) (mean: 0.3) | 0.2 (0.1–0.3) (mean: 0.4) | < 0.01 |
PFHxS, ng/mL | 1.2 (0.7–2.1) | 1.1 (0.6–1.9) | 1.4 (0.8–2.4) | < 0.01 |
PFNA, ng/mL | 0.6 (0.4–0.9) | 0.5 (0.3–0.9) | 0.7 (0.4–1.1) | < 0.01 |
n-PFOA, ng/mL | 1.5 (1.0–2.4) | 1.4 (0.9–2.2) | 1.8 (1.1–2.7) | < 0.01 |
n-PFOS, ng/mL | 3.4 (2.0–6.0) | 3.0 (1.8–5.1) | 4.3 (2.5–8.0) | < 0.01 |
Sm-PFOS, ng/mL | 1.0 (0.8–2.5) | 1.2 (0.7–2.1) | 2.0 (1.1–3.4) | < 0.01 |
